Mean daily use of oral corticosteroids per person per day · people with asthma
1 finding from 1 review
Intervention not reported
Number of participants requiring oral corticosteroids over the study period · Adults from minority groups with doctor diagnosed asthma
It is very uncertain whether the intervention changes number of participants requiring oral corticosteroids over the study… (very low certainty).
1 finding from 1 review
Pain score during procedure: oral opioid · women undergoing outpatient hysteroscopy
1 finding from 1 review
Pain score within 30 min of procedure oral opioid · women undergoing outpatient hysteroscopy
1 finding from 1 review
Pain score more than 30 min after procedure oral opioid · women undergoing outpatient hysteroscopy
1 finding from 1 review
Global state: needing additional medication (sedation with chloral hydrate or a barbiturate > 5 times) ‐ medium term · patients with schizophrenia
CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) showed no clear difference in global state: needing additional medication (sedation with chloral… compared with MEDIUM DOSE (401 mg/day to 800 mg/day) (low certainty).
1 finding from 1 review
Global state: needing additional medication (sedation with chloral hydrate or a barbiturate > 5 times) ‐ medium term · schizophrenia
1 finding from 1 review
Rescue analgesia · analgesia in traumatic corneal abrasions
Topical NSAIDs may leads to lower use of rescue oral analgesia at 24 hours compared with control (low certainty).
2 findings from 1 review
Intervention not reported
Patients with ≥ 1 exacerbations requiring oral corticosteroids Duration of trials: 6 to 16 weeks · adults and adolescents with persistent asthma
The intervention probably leads to lower patients with ≥ 1 exacerbations requiring oral corticosteroids… (moderate certainty).
1 finding from 1 review
Intervention not reported
Participants with ≥ 1 exacerbation requiring oral corticosteroids Duration of trials: 8 to 24 weeks · adults and adolescents with persistent asthma
The intervention showed no clear difference in participants with ≥ 1 exacerbation requiring oral corticosteroids… (low certainty).
1 finding from 1 review
Intervention not reported
Patients with ≥ 1 exacerbation requiring oral corticosteroids Duration of trials: 8 to 13 weeks · adults and adolescents with persistent asthma
The intervention showed no clear difference in patients with ≥ 1 exacerbation requiring oral corticosteroids… (moderate certainty).
1 finding from 1 review
Intervention not reported
Other adverse effects of intubation in children, including trauma to oral, pharyngeal, and laryngeal structures, assessed by visual or laryngoscopic examination · tracheal intubation in children (excluding neonates)
1 finding from 1 review
Courses of oral corticosteroids · patients with chronic obstructive pulmonary disease
Self‐management interventions including action plans for exacerbations showed no clear difference in courses of oral steroids compared with usual care (low certainty).
1 finding from 1 review
Intervention not reported
Incidence of T2DM Definition/description: 1 trial established the diagnosis of T2DM defined as HbA1c ≥ 6.5%, or fasting plasma glucose ≥ 7.0 mmol/L, or 2‐hour plasma glucose post‐challenge (oral glucose tolerance test) ≥ 11.1 mmol/L (SCALE). Other... · people at risk for development of T2DM
1 finding from 1 review
Gavage to full oral feeding (days) · preterm infants
1 finding from 1 review
Start oral feeding to full oral feeding (days) · preterm infants
1 finding from 1 review
Days from birth to full oral breastfeeding · preterm infants
1 finding from 1 review
Postconceptual age at full oral feeds (days) · preterm infants
1 finding from 1 review
Femoral neck bone mineral density (FN-BMD) · adults with GIOP
1 finding from 1 review
Improvement in disability grade after 4 weeks · patients with Guillain‐Barré syndrome
1 finding from 1 review